Comments on: Merck’s Januvia Is The Next Target http://www.pharmalot.com/2007/06/mercks-januvia-is-the-next-target/ News, Comment and Conversation Sat, 20 Mar 2010 23:41:30 +0000 http://wordpress.org/?v=2.6.2 By: Laurie http://www.pharmalot.com/2007/06/mercks-januvia-is-the-next-target/#comment-3779 Laurie Thu, 07 Jun 2007 22:18:45 +0000 http://www.pharmalot.com/2007/06/mercks-januvia-is-the-next-target/#comment-3779 The big question is have those that are taking this drug been told that they are participating in a clinical trial..without even knowing it!! The big question is have those that are taking this drug been told that they are participating in a clinical trial..without even knowing it!!

]]> By: Ed Silverman http://www.pharmalot.com/2007/06/mercks-januvia-is-the-next-target/#comment-3778 Ed Silverman Thu, 07 Jun 2007 22:15:35 +0000 http://www.pharmalot.com/2007/06/mercks-januvia-is-the-next-target/#comment-3778 Hey Huh? Yes, it's a good question. That's why I think it will be a long seven years - for everyone. Thanks for stopping by. ed Hey Huh?

Yes, it’s a good question. That’s why I think it will be a long seven years - for everyone.

Thanks for stopping by.

ed

]]> By: Huh? http://www.pharmalot.com/2007/06/mercks-januvia-is-the-next-target/#comment-3776 Huh? Thu, 07 Jun 2007 21:50:40 +0000 http://www.pharmalot.com/2007/06/mercks-januvia-is-the-next-target/#comment-3776 They want consumers to wait 7 years before taking the drug, so they can have more market data. Where are they going to get the market data if consumers aren't taking it? Are there Phase IV studies ongoing with planned follow-up in 2014??? They want consumers to wait 7 years before taking the drug, so they can have more market data. Where are they going to get the market data if consumers aren’t taking it? Are there Phase IV studies ongoing with planned follow-up in 2014???

]]> By: Dr. Remulac http://www.pharmalot.com/2007/06/mercks-januvia-is-the-next-target/#comment-3761 Dr. Remulac Thu, 07 Jun 2007 14:12:11 +0000 http://www.pharmalot.com/2007/06/mercks-januvia-is-the-next-target/#comment-3761 Tricor (fenofibrate) is already on Public Citizen's list of top 200 worst drugs. Despite a lack of meaningful data on beneficial clinical outcomes and a very alarming signal of harm when combined with a statin in their one and only longterm event trial (FIELD), this drug is a >$1 billion seller. Scary! Tricor (fenofibrate) is already on Public Citizen’s list of top 200 worst drugs. Despite a lack of meaningful data on beneficial clinical outcomes and a very alarming signal of harm when combined with a statin in their one and only longterm event trial (FIELD), this drug is a >$1 billion seller. Scary!

]]>